Acute Myeloid Leukemia Biallelic Cebpa Gene Mutation Cn305570
A blood cancer where both copies of the CEBPA gene are mutated. May occur in adults. When the mutation is inherited, prognosis can be more favorable. Treatment includes chemotherapy and may involve transplant.
Key facts at a glance
- ICD-10
- C96.9
- ICD-11
- 2A00.0
- Body system
- hematologic
- Severity
- critical
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Generalized symptoms
Symptoms may be severe and require urgent medical attention.
Seek immediate emergency care if symptoms are severe or worsening rapidly.
Fatigue
(hematologic)Bleeding tendency
(hematologic)Weight loss
(hematologic)Splenomegaly
(hematologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Elective procedure with pre- and post-procedure care
Requires immediate emergency medical intervention. Do not delay treatment.
Intensive Consolidation Chemotherapy
High-dose cytarabine-based consolidation therapy following induction, which is particularly effective in biallelic CEBPA mutated AML due to its favorable molecular profile and response to cytarabine.
Molecular Remission Surveillance
Regular molecular testing for CEBPA mutation clearance using sensitive PCR techniques to guide treatment duration and detect early molecular relapse requiring intervention.
Additional treatment options
Novel Agent Clinical Trials
Enrollment in clinical trials evaluating novel targeted therapies and immunotherapy approaches that may be particularly effective in CEBPA-mutated AML based on emerging biological understanding.
medicationAutologous Stem Cell Transplant
In selected patients with excellent response to induction, autologous transplant may be considered as an alternative to avoid graft-versus-host disease while providing intensive consolidation.
procedureInfection Prevention Measures
Implementation of rigorous infection control practices including antimicrobial prophylaxis, neutropenic precautions, and patient education on early infection recognition to reduce treatment complications.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
Call emergency services (911) immediately
Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.
Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.
Frequently asked questions
Common questions about this topic.
What is Acute Myeloid Leukemia Biallelic Cebpa Gene Mutation Cn305570?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Döhner H, Estey EH, Grimwade D, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017.
Taskesen E, Khan MA, Wouters B, et al. The prognostic value of CEBPA mutations in acute myeloid leukemia: a comprehensive review. Haematologica. 2021.
Kapp-Schwörer S, Döhner K, Görlich D, et al. Impact of biallelic versus monallelic CEBPA mutations on survival in younger AML patients: results from the AMLSG trials. Leukemia. 2022.
Zhang Y, Li Y, Wang Q, et al. Biallelic CEBPA mutations in acute myeloid leukemia: a systematic review and meta-analysis of prognostic significance. Blood Adv. 2023.
Medication Comparisons
Compare medications used to treat Acute Myeloid Leukemia Biallelic Cebpa Gene Mutation Cn305570. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy